8 March 2017 - Deborah Wilkes
Archived
Belgium's Federal Agency for Medicines and Health Products (FAMHP) is encouraging companies to switch their nasal corticosteroids from prescription to non-prescription status.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.